Clinical Trial Update: Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne [Phase 3]

View source ↗

Summary

ACYC, sponsored by Bausch Health Americas, completed its Phase 3 trial for moderate to severe acne and posted results in January 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne

Drugs mentioned

• ACYC

Snippet

Sponsor: Bausch Health Americas, Inc. | Conditions: Acne | Phase 3 | Status: COMPLETED | Results posted: 2017-01-10